Comparing the current results to its competitors, Syneos Health Inc reported Revenue increase in the 2 quarter 2023 by 0.39 % year on year, while most of its competitors have experienced contraction in revenues by -18.5 %, achieved in the same quarter.
Syneos Health Inc Net Income in the 2 quarter 2023 fell year on year by -98.98%, while most of its competitors have experienced a contraction in net income by -21.66 %.
Medpace Holdings Inc is a contract research organization (CRO) that provides various services in the clinical research and development of drugs and medical devices.
Inotiv Inc is a contract research organization (CRO) that provides preclinical and nonclinical research services to the pharmaceutical, biotechnology, and medical device companies. The company offers a range of services including drug discovery, safety assessment, toxicology testing, and analytical services. By assisting clients with their research and development needs, Inotiv aims to contribute to the advancement of medicine and the development of new treatment options.
Labcorp Holdings Inc operates as a major healthcare diagnostics company, providing clinical laboratory tests and services to healthcare providers, pharmaceutical companies, and government agencies. Their business model emphasizes delivering accurate and timely test results to aid in patient diagnosis, treatment, and monitoring.
IQVIA Holdings Inc operates a multifaceted business model that focuses on delivering advanced analytics, technology solutions, and clinical research services tailored for the healthcare sector. By harnessing extensive data resources and industry expertise, the company aids clients in optimizing operations, enhancing drug development processes, and ultimately improving patient outcomes.
Icon Plc is a leading provider of clinical research services, specializing in the design and management of clinical trials for pharmaceutical and biotechnology companies. Their business model focuses on offering a comprehensive range of services, including study design, data management, regulatory support, and statistical analysis, to support the development of new drugs and medical devices. Icon Plc's success lies in its ability to provide customized solutions to its clients, efficiently navigate the regulatory landscape, and consistently deliver high-quality and timely results.
Sources:
Syneos Health Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Syneos Health Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
